1y return+94.8%S&P 500 +20.9%
3y return+156.7%S&P 500 +68.5%
5y return−23.9%S&P 500 +74.5%
10y return+5.1%S&P 500 +256.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since June 30, 2016: $105 against $357 in the S&P 500.2
Alphabet Inc.S&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| SPCXSpace Exploration Techn Corp | $94.2B | 95.0% | New |
| PLPlanet Labs Pbc | $1.2B | 1.2% | |
| ASTSAst Spacemobile Inc | $794.7M | 0.8% | |
| CMECme Group Inc | $769.4M | 0.8% | |
| ARMArm Holdings PLC | $695.2M | 0.7% | |
| RVMDRevolution Medicines Inc | $551.8M | 0.6% | −10.5% |
| FRSHFreshworks Inc | $164.0M | 0.2% | |
| PBLSParabilis Medicines Inc | $134.6M | 0.1% | New |
| TEMTempus Ai Inc | $89.9M | 0.1% | |
| GTLBGitlab Inc | $83.2M | 0.1% | |
| PATHUipath Inc | $76.5M | 0.1% | |
| LIFEEthos Technologies Inc | $65.7M | 0.1% | −3.9% |
| PRMEPrime Medicine Inc | $61.1M | 0.1% | |
| FRVOFervo Energy Co | $51.5M | 0.1% | New |
| PAYPPaypay Corp | $44.8M | 0.0% | |
| MAZEMaze Therapeutics Inc | $41.4M | 0.0% | |
| RLAYRelay Therapeutics Inc | $26.4M | 0.0% | −9.9% |
| BBOTBridgebio Oncology Therapeut | $21.5M | 0.0% | |
| OSCROscar Health Inc | $13.7M | 0.0% | |
| BEAMBeam Therapeutics Inc | $11.0M | 0.0% | |
| VERAVera Therapeutics Inc | $10.4M | 0.0% | |
| SANASana Biotechnology Inc | $9.8M | 0.0% | |
| GLUEMonte Rosa Therapeutics Inc | $9.0M | 0.0% | −45.6% |
| LYELLyell Immunopharma Inc | $4.1M | 0.0% | |
| FIGFigma Inc | $3.9M | 0.0% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| ARMArm Holdings PLC | September 30, 2023 | +562.5% | $695.2M |
| RVMDRevolution Medicines Inc | December 31, 2023 | +553.0% | $551.8M |
| PLPlanet Labs Pbc | December 31, 2021 | +438.7% | $1.2B |
| ASTSAst Spacemobile Inc | March 31, 2025 | +290.8% | $794.7M |
| VERAVera Therapeutics Inc | June 30, 2021 | +223.8% | $10.4M |
| MAZEMaze Therapeutics Inc | March 31, 2025 | +171.0% | $41.4M |
| TEMTempus Ai Inc | June 30, 2024 | +65.5% | $89.9M |
| LIFEEthos Technologies Inc | March 31, 2026 | +62.4% | $65.7M |
| LYELLyell Immunopharma Inc | June 30, 2025 | +58.9% | $4.1M |
| GLUEMonte Rosa Therapeutics Inc | June 30, 2021 | +6.6% | $9.0M |
Sold off last quarter
- TNYATenaya Therapeutics Inc was $632K
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +19.5% | +14.8% |
| March 31, 2026 | +10.9% | −4.6% |
| December 31, 2025 | +22.8% | +2.4% |
| September 30, 2025 | +19.6% | +7.8% |
| June 30, 2025 | +38.3% | +10.5% |
| March 31, 2025 | −12.9% | −4.6% |
| December 31, 2024 | +5.9% | +2.1% |
| September 30, 2024 | −3.8% | +5.4% |
| June 30, 2024 | −13.0% | +4.0% |
| March 31, 2024 | +9.0% | +10.0% |
| December 31, 2023 | +30.5% | +11.2% |
| September 30, 2023 | −13.2% | −3.6% |
| June 30, 2023 | +8.8% | +8.3% |
| March 31, 2023 | +2.3% | +7.0% |
| December 31, 2022 | −23.7% | +7.1% |
| September 30, 2022 | +15.1% | −5.3% |
| June 30, 2022 | −35.6% | −16.5% |
| March 31, 2022 | −28.4% | −4.9% |
| December 31, 2021 | −23.1% | +10.7% |
| September 30, 2021 | −14.4% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Alphabet Inc. Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1652044&type=13F-HR&dateb=&owner=include&count=40CIK 1652044
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1652044/000165204426000073/Filed August 7, 2026 · accession 0001652044-26-000073